Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Enzyme-Linked Immunosorbent Assay01:33

Enzyme-Linked Immunosorbent Assay

17.3K
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or...
17.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Transcriptomic and proteomic assessment of radiation injury and dose-rate dependency in white blood cells.

Journal of radiological protection : official journal of the Society for Radiological Protection·2026
Same author

Immunoproteomics: The Evolution from Classical Methods to Emerging Techniques.

Methods in molecular biology (Clifton, N.J.)·2025
Same author

Editorial: The role of microbial glycosylation in host-pathogen interactions.

Frontiers in cellular and infection microbiology·2025
Same author

Dose-response modeling reveals multifaceted molecular responses to low-dose radiation in human white blood cells.

International journal of radiation biology·2025
Same author

Polar flagellin glycan heterogeneity of Aeromonas hydrophila strain ATCC 7966<sup>T</sup>.

Bioorganic chemistry·2025
Same author

Integration of multi-omics and benchmark dose modeling to support adverse outcome pathways.

International journal of radiation biology·2025

相关实验视频

Updated: Jan 15, 2026

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
09:12

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection

Published on: June 15, 2018

10.4K

血清蛋白质组分析用于抗原鉴定.

Susan M Twine1, Kelly M Fulton2

  • 1Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, ON, Canada.

Methods in molecular biology (Clifton, N.J.)
|October 14, 2025
PubMed
概括
此摘要是机器生成的。

血清蛋白质组分析 (SERPA) 通过分析抗体反应来识别疾病特异性抗原. 这种免疫蛋白组学方法有助于开发疫苗和诊断生物标志物.

关键词:
抗原是一种抗原.生物标志物 生物标志物弗朗西塞拉 (Francisella tularensis) 是一种的植物.免疫蛋白质组学 免疫蛋白质组学免疫活性 免疫活性在 SERPA 中,我们可以使用 SERPA.血清学蛋白质组分析西方涂抹是指西方涂抹.

更多相关视频

Author Spotlight: Advancing Antiviral Strategies Through Novel Immunocapture and Mass Spectrometry Techniques
08:07

Author Spotlight: Advancing Antiviral Strategies Through Novel Immunocapture and Mass Spectrometry Techniques

Published on: January 12, 2024

1.2K
Author Spotlight: Expanding the Scope of Multiplex Immunoassays for Lyme Borreliosis Diagnostics and Pathogen Research
05:25

Author Spotlight: Expanding the Scope of Multiplex Immunoassays for Lyme Borreliosis Diagnostics and Pathogen Research

Published on: July 14, 2023

1.9K

相关实验视频

Last Updated: Jan 15, 2026

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
09:12

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection

Published on: June 15, 2018

10.4K
Author Spotlight: Advancing Antiviral Strategies Through Novel Immunocapture and Mass Spectrometry Techniques
08:07

Author Spotlight: Advancing Antiviral Strategies Through Novel Immunocapture and Mass Spectrometry Techniques

Published on: January 12, 2024

1.2K
Author Spotlight: Expanding the Scope of Multiplex Immunoassays for Lyme Borreliosis Diagnostics and Pathogen Research
05:25

Author Spotlight: Expanding the Scope of Multiplex Immunoassays for Lyme Borreliosis Diagnostics and Pathogen Research

Published on: July 14, 2023

1.9K

科学领域:

  • 免疫蛋白质组学 免疫蛋白质组学
  • 生物标志物发现发现
  • 疫苗开发 疫苗开发

背景情况:

  • 血清蛋白质组分析 (SERPA) 是一种成熟的免疫蛋白质组技术.
  • 它评估对疾病,疫苗和治疗药物的幽默性免疫反应.
  • 塞尔帕适用于各种领域,包括传染病,瘤学和自身免疫性疾病.

研究的目的:

  • 为执行SERPA提供详细,逐步的说明.
  • 从优化方法的广泛经验中提供实用的见解.
  • 突出SERPA在识别疾病特异性抗原中的实用性.

主要方法:

  • 结合了二维的西方涂抹与质谱学.
  • 分析抗体对蛋白质组的反应性.
  • 识别引起免疫反应的特定抗原.

主要成果:

  • 能够识别负责产生抗体的单个抗原.
  • 促进对幽默性免疫反应的理解.
  • 为进一步的研究和应用提供了基础.

结论:

  • 塞尔帕是一种用于剖析免疫反应的多功能工具.
  • 已识别的抗原可用于亚单位疫苗生产.
  • 来自SERPA的信息对诊断生物标志物开发有价值.